Korro Bio Inc. (KRRO)
21.45
-1.51 (-6.58%)
At close: Mar 04, 2025, 12:51 PM
Korro Bio Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | n/a | n/a | 14.07M | 36.98M | 28.95M | n/a | n/a |
| Cost of Revenue | 3.63M | 2.51M | 3.84M | 1.58M | 16.81M | 654K | 531K |
| Gross Profit | -3.63M | -2.51M | 10.23M | 35.4M | 12.13M | -654K | -531K |
| Operating Income | -84.53M | -59M | -35.49M | -27.55M | -20.68M | -18.94M | -16.31M |
| Interest Income | n/a | 947K | n/a | 994K | 1.78M | n/a | n/a |
| Pretax Income | -81.14M | -58.02M | -21.96M | -26.48M | -18.75M | -19.17M | -20.24M |
| Net Income | -81.17M | -58.03M | -21.96M | -26.51M | -18.75M | -19.17M | -20.24M |
| Selling & General & Admin | 27.28M | 16.8M | 11.69M | 26.3M | 14.47M | 6.71M | 3.99M |
| Research & Development | 57.25M | 42.2M | 23.8M | 36.66M | 18.33M | 11.58M | 11.79M |
| Other Expenses | n/a | 976K | 13.54M | n/a | n/a | n/a | n/a |
| Operating Expenses | 84.53M | 59M | 35.49M | 62.95M | 32.81M | 18.29M | 15.78M |
| Interest Expense | n/a | 118K | n/a | n/a | n/a | 106K | 174K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 84.53M | 59M | 35.49M | 64.53M | 49.62M | 18.94M | 16.31M |
| Income Tax | 27K | 10K | 2K | 35K | n/a | n/a | 1.00 |
| Shares Outstanding (Basic) | 1.53M | 255K | 4.45M | 645.06K | 616.89K | 627.09K | 627.09K |
| Shares Outstanding (Diluted) | 1.53M | 255.17K | 4.45M | 645.06K | 616.89K | 627.09K | 627.09K |
| EPS (Basic) | -53.09 | -227.58 | -4.94 | -41.1 | -30.39 | -30.57 | -32.27 |
| EPS (Diluted) | -53.08 | -227.42 | -4.94 | -41.1 | -30.39 | -30.57 | -32.27 |
| EBITDA | -80.9M | -56.49M | -33.9M | -24.9M | -17.93M | -18.41M | -19.53M |
| Depreciation & Amortization | 3.63M | 2.51M | 3.84M | 1.58M | 813K | 654K | 531K |